Sign in

CIK 0000876343

  • Non-accelerated filer
  • Smaller reporting company

Lineage Cell Therapeutics, Inc.

Sign in to watch
Ticker
LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
943127919
Phone
+1 510-521-3390
Business address
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
Former names
BIOTIME INC
  1. 4 Open-market sale Director sold 5,000 shares at an average $3.51 ($17,525)
  2. 3/A Insider 3/A
  3. 4 Option exercise 10% owner acquired 1,100,000 shares (option exercise)
  4. 4 Other acquisition 10% owner acquired 1,100,000 shares (other)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market sale Director sold 1,000 shares at $2.50 ($2,500)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Open-market sale Director sold 32,332 shares at an average $2.39 ($77,305)
  12. 4 Open-market sale Vice President sold 36,000 shares at an average $2.88 ($103,528)
  13. 4 Open-market sale CFO sold 22,500 shares at an average $2.54 ($57,156)
  14. 4 Open-market sale Vice President & Secretary sold 45,000 shares at an average $2.44 ($109,699)
  15. 4 Open-market sale Vice President sold 45,000 shares at an average $2.66 ($119,790)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Other acquisition 10% owner acquired 1,100,000 shares (other)
  18. 4 Other acquisition 10% owner acquired 13,144 shares (other)
  19. 4 Other acquisition 10% owner acquired 3,429 shares (other)
  20. 4 Other acquisition 10% owner acquired 7,000 shares (other)

Page 23 of 37 · 722 filings